Hosted on MSN31m
JP Morgan 2025: Incyte expects period of ‘defining catalysts’Incyte CEO Hervé Hoppenot has promised investors that 2025 will be “a year that will be full of many defining catalysts” for ...
At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.
Zimmer Biomet expressed its optimism that the company will strengthen its market return in 2025 during the JP Morgan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback